Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...
Drugs from Ionis and Arrowhead Pharma that block ... and ultra-rare disorder familial chylomicronaemia syndrome (FCS). At ACC, Ionis reported results from the phase 3 BALANCE trial of its ...
DUBLIN and BRIDGEWATER, N.J. - Amarin Corporation plc (NASDAQ:AMRN) announced today that it will present new in vitro data on its cardiovascular drug at the upcoming American College of Cardiology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results